An in silico-in vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Author(s):
Mishto, M.; Mansurkhodzhaev, A.; Ying, G.; Bitra, A.; Cordfunke, R.A.; Henze, S.; Paul, D.; Sidney, J.; Urlaub, H.; Neefjes, J.; Sette, A.; Zajonc, D.M.; Liepe, J.
Published
2019
Publication type
Article / Letter to editor
proteasomepeptide splicingadoptive T cell therapy targetsantigen presentationcancer epitopesKRAStumor immunology
Date issued
2019-11-15
Language
English
Is part of
Frontiers in Immunology
hdl
1887/120727
doi
10.3389/fimmu.2019.02572